首页> 美国卫生研究院文献>Scientific Reports >Improved genome-scale multi-target virtual screening via a novel collaborative filtering approach to cold-start problem
【2h】

Improved genome-scale multi-target virtual screening via a novel collaborative filtering approach to cold-start problem

机译:通过新颖的协同过滤方法解决冷启动问题改进了基因组规模的多目标虚拟筛选

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Conventional one-drug-one-gene approach has been of limited success in modern drug discovery. Polypharmacology, which focuses on searching for multi-targeted drugs to perturb disease-causing networks instead of designing selective ligands to target individual proteins, has emerged as a new drug discovery paradigm. Although many methods for single-target virtual screening have been developed to improve the efficiency of drug discovery, few of these algorithms are designed for polypharmacology. Here, we present a novel theoretical framework and a corresponding algorithm for genome-scale multi-target virtual screening based on the one-class collaborative filtering technique. Our method overcomes the sparseness of the protein-chemical interaction data by means of interaction matrix weighting and dual regularization from both chemicals and proteins. While the statistical foundation behind our method is general enough to encompass genome-wide drug off-target prediction, the program is specifically tailored to find protein targets for new chemicals with little to no available interaction data. We extensively evaluate our method using a number of the most widely accepted gene-specific and cross-gene family benchmarks and demonstrate that our method outperforms other state-of-the-art algorithms for predicting the interaction of new chemicals with multiple proteins. Thus, the proposed algorithm may provide a powerful tool for multi-target drug design.
机译:传统的单药一基因方法在现代药物发现中取得了有限的成功。多元药理学已经成为一种新的药物发现范式,其重点是寻找能扰乱致病网络的多靶点药物,而不是设计针对单个蛋白质的选择性配体。尽管已经开发了许多用于单目标虚拟筛选的方法来提高药物发现的效率,但是这些算法中很少有针对多药理学设计的。在这里,我们提出了一种基于一类协同过滤技术的基因组规模多目标虚拟筛选的新颖理论框架和相应算法。我们的方法通过相互作用矩阵加权和来自化学物质和蛋白质的双重正则化方法克服了蛋白质-化学相互作用数据的稀疏性。尽管我们方法背后的统计基础足以涵盖全基因组范围的脱靶药物预测,但该程序是专门为寻找新化学物质的蛋白质靶标而设计的,几乎没有可用的相互作用数据。我们使用许多最广泛接受的基因特异性和跨基因家族基准对我们的方法进行了广泛的评估,并证明了我们的方法优于其他最新算法来预测新化学物质与多种蛋白质的相互作用。因此,提出的算法可以为多目标药物设计提供强大的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号